GLATIRAMER Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Glatiramer, and when can generic versions of Glatiramer launch?
Glatiramer is a drug marketed by Chemi Spa, Hybio, Mylan, Scinopharm Taiwan, and Synthon Pharms Inc. and is included in eight NDAs.
The generic ingredient in GLATIRAMER is glatiramer acetate. There are five drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the glatiramer acetate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Glatiramer
A generic version of GLATIRAMER was approved as glatiramer acetate by MYLAN on October 3rd, 2017.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for GLATIRAMER?
- What are the global sales for GLATIRAMER?
- What is Average Wholesale Price for GLATIRAMER?
Summary for GLATIRAMER
| US Patents: | 0 |
| Applicants: | 5 |
| NDAs: | 8 |
| Drug Prices: | Drug price information for GLATIRAMER |
| DailyMed Link: | GLATIRAMER at DailyMed |
US Patents and Regulatory Information for GLATIRAMER
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chemi Spa | GLATIRAMER ACETATE | glatiramer acetate | INJECTABLE;SUBCUTANEOUS | 208468-001 | May 7, 2025 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Scinopharm Taiwan | GLATIRAMER ACETATE | glatiramer acetate | INJECTABLE;SUBCUTANEOUS | 214741-001 | Dec 31, 2025 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Hybio | GLATIRAMER ACETATE | glatiramer acetate | INJECTABLE;SUBCUTANEOUS | 214022-001 | Feb 11, 2026 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Scinopharm Taiwan | GLATIRAMER ACETATE | glatiramer acetate | INJECTABLE;SUBCUTANEOUS | 214741-002 | Dec 31, 2025 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Chemi Spa | GLATIRAMER ACETATE | glatiramer acetate | INJECTABLE;SUBCUTANEOUS | 208468-002 | May 7, 2025 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Hybio | GLATIRAMER ACETATE | glatiramer acetate | INJECTABLE;SUBCUTANEOUS | 213382-001 | Feb 11, 2026 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
